1. Advances in Cystic Fibrosis Views and Perspectives From Basel, Switzerland, 2016

3. Infection and Microbiota of the Lung and Gut

4. Predictors of IV Antibiotic Treatment Failure

5. Findings

6. Trends in Pseudomonas Infection, UK Registry Data

7. Unexpected Findings

8. Effect of Changes in Gut Microbiota in CF

9. CFTR Modulator Ivacaftor Experience

10. Analysis of Disease Progression With Ivacaftor

11. Findings

12. Question?

13. Effect of CFTR Modulator Therapy on Airway Bacterial Composition

14. Findings

15. Inflammation and the Microbiome

16. Effects of Lumacaftor/Ivacaftor on Biomarkers of Systemic Inflammation

17. CF-SpIT Study Lower Airway Microbiome in Young Children

18. Predictive Markers of PA Infection

19. Perspective

20. Patient Education and Self-Management Tools

21. What Do Patients Want From an Electronic Clinical Record?

22. Patient Preferences in ECR

23. Patient Perspectives on Access to Registry Data

24. Access to Registry Data

25. Patient Education Linked to Quality Improvement Program

26. Findings

27. Abbreviations

28. Abbreviations